Position in CGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$467,942
-$355,371 QoQ
Shares Held
492,571
-43.2% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 212 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$857,072
PutShares
312,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. CGC ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in CGC
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $467,942 | 492,571 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $823,313 | 867,559 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $802,965 | 704,356 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,581,036 | 3,137,696 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,289,176 | 1,056,702 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,674,134 | 1,839,708 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $857,072 | 312,800 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $1,468,664 | 536,009 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,507,696 | 312,800 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $1,736,053 | 360,177 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $782,952 | 121,388 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,738,928 | 317,373 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $456,133 | 89,263 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,157,908 | 1,478,810 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $8,653,716 | 11,052,000 | Principal | Sole | 2023-11-14 | |
| 2023-06-30 | $201,218 | 518,605 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $19,765,875 | 8,556,656 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $1,111 | 355,100 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $970,242 | 355,400 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $8,442,727 | 3,092,574 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $998,925 | 350,500 | Call | Sole | 2022-08-15 | |
| 2022-06-30 | $8,984,884 | 3,152,591 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,656,790 | 350,500 | Call | Sole | 2022-05-16 | |
| 2021-12-31 | $165,747 | 18,986 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,125,916 | 153,385 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $546,129 | 22,586 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,998,433 | 124,834 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,894,386 | 117,467 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $601,135 | 37,199 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,203,161 | 83,437 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||